When developing a new product, the belief is that every month of lead time ahead of a competitor is a significant advantage, but it’s not quite that simple. This article seeks to identify those situations where first-to-market advantage is strong and those where it does not hold. Read more here. (Source: Myoung Cha and Flora Yu, Insights & Publications, Sept 2014).
You are here: / / Pharma – What’s The Real Value Of Bringing A Drug To Market First?